Where we’re at

Today, SpecialtyRx stands as the largest privately-owned long-term care pharmacy in the nation.
But behind every impressive statistic is the same caring spirit that started it all:

1150+

0

+
facilities

proudly serviced

65,000+

0

+
medications

produced daily

350K+

0

K+
patients

served annually
nationwide

21+

0

+
years

helping loved ones
live healthier lives

Star Shadow
OUR LOCATIONS
National reach.
Personal touch.

Serving over 100,000 patients across 17 states, and growing.

Serving over 350,000 patients annually across 18 states, and growing.
Gl
Our difference

Building the world’s most
patient-centered LTC pharmacy

Each day, we're helping nurses save time, prescriptions become more precise, costs more manageable, and patients grow healthier.

Services that transform care for those in need

Precise, swift, and cost-effective paths to treatment.

Technology that helps providers breathe easier

Instant communication, transparency, and clarity at every step.

Culture that supports our people and fuels success

Colleagues who challenge, inspire, and bring out the best in one another.

SpecialtyRx

Our team. Your heroes.

SpecialtyRx care means finding exceptional ways to be there for patients and providers.

Honoring our people

Hall of Caring

Caring isn’t just a word. It’s a thousand acts each day.
Hall of Caring
Medication for those in need

Giving back

$8,000,000+ in drugs donated annually — because health shouldn’t be a luxury.
Giving back
LATEST UPDATES

The Pulse

Experience SpecialtyRx — with essential, up-to-date information on everything pharmacy.

Appropriate use of Journavx (Suzetrigine)
JOURNAVX® (suzetrigine) is a first-in-class, non-opioid analgesic approved by the FDA for the treatment of moderate to severe short term acute pain in adults, including postoperative pain.
JOURNAVX® (suzetrigine) is a first-in-class, non-opioid analgesic approved by the FDA for the treatment of moderate to severe short term acute pain in adults, including postoperative pain.
September 2026

Appropriate use of Journavx (Suzetrigine)

JOURNAVX® (suzetrigine) is a first-in-class, non-opioid analgesic approved by the FDA for the treatment of moderate to severe short term acute pain in adults, including postoperative pain.
Influenza 2026-27 Season Vaccination Updates for Nursing Homes 
Early preparation and prompt influenza vaccination help protect residents, reduce outbreaks, and support a safer healthcare environment throughout the flu season. Facilities should ensure vaccine ordering, consent collection, staff education, and VIS distribution are in place before vaccine shipments arrive.
Early preparation and prompt influenza vaccination help protect residents, reduce outbreaks, and support a safer healthcare environment throughout the flu season. Facilities should ensure vaccine ordering, consent collection, staff education, and VIS distribution are in place before vaccine shipments arrive.
September 2026

Influenza 2026-27 Season Vaccination Updates for Nursing Homes 

Early preparation and prompt influenza vaccination help protect residents, reduce outbreaks, and support a safer healthcare environment throughout the flu season. Facilities should ensure vaccine ordering, consent collection, staff education, and VIS distribution are in place before vaccine shipments arrive.
New Oral Covid-19 Option for Nursing Homes – XOCOVA
XOCOVA (ensitrelvir) is a new oral antiviral approved for post-exposure prophylaxis of COVID-19 in adults and adolescents 12 years and older after being in contact with someone who has COVID-19. In nursing home settings, staff should know when it may be used, how it is dosed, and what safety checks are required before administration.
XOCOVA (ensitrelvir) is a new oral antiviral approved for post-exposure prophylaxis of COVID-19 in adults and adolescents 12 years and older after being in contact with someone who has COVID-19. In nursing home settings, staff should know when it may be used, how it is dosed, and what safety checks are required before administration.
September 2026

New Oral Covid-19 Option for Nursing Homes – XOCOVA

XOCOVA (ensitrelvir) is a new oral antiviral approved for post-exposure prophylaxis of COVID-19 in adults and adolescents 12 years and older after being in contact with someone who has COVID-19. In nursing home settings, staff should know when it may be used, how it is dosed, and what safety checks are required before administration.
EVENTS
EVENTS

Florida health care association annual conference Jul 31 – Aug 4

Come visit us at booth #1114-1116 at the 2022 Florida Health Care Association Annual Conference and Trade Show.


news
news

Brain health negatively impacted by lack of green space

According to a study published in Alzheimer’s & Dementia: Diagnosis, Assessment, & Disease Monitoring, older adults who lack access to green spaces, even a small garden or tree, spe

FDA updates
FDA updates

New HIPAA regulations on the way

New HIPAA requirements are coming soon. Smart facilities will begin making preparations now so when these new rules go into effect, they will be compliant. There are two significan

Join 1150+ facilities powering their operations forward with America's leading LTC pharmacy
Join 850+ facilities powering their operations forward with America's leading LTC pharmacy
Coming soon